Comparing TA-TAVR and SAVR in severe aortic regurgitation: outcomes and valve haemodynamics [0.03%]
严重主动脉反流经导管与外科主动脉瓣置换术的临床及血流动力学对比研究
Ziyan He,Dekun Cai,Mingwen Li et al.
Ziyan He et al.
Background: Transcatheter aortic valve replacement (TAVR) has already been recommended for some high-risk patients with aortic valve regurgitation, but there is still a lack of evidence regarding its early-term and medium...
Comparative Study
Open heart. 2026 Mar 23;13(1):e003969. DOI:10.1136/openhrt-2026-003969 2026
Beyond the tear: the enduring role of aortic pathology in the era of genomic medicine [0.03%]
基因组医学时代主动脉病理在马凡综合征中的持久作用
Nimrat Grewal,Hans W M Niessen
Nimrat Grewal
Thoracic aortic dissection is often approached as an acute and localised event, and pathological examination has traditionally focused on the dissected segment. In daily practice, however, most clinicians recognise that the dissection itsel...
Biomarkers of iron deficiency and prognosis in patients hospitalised with new-onset heart failure and a reduced left ventricular ejection fraction [0.03%]
铁减低生物标志物与射血分数降低的新发心力衰竭住院患者的预后关系
Jonathan S M Johansson,Josefin Henrysson,Carmen Basic et al.
Jonathan S M Johansson et al.
Background: Iron deficiency (ID) is common in patients with heart failure (HF). Current guidelines define ID based on serum ferritin and transferrin saturation (TSAT) rather than soluble transferrin receptor (STFR) or rat...
ST-segment elevation in acute pericarditis and myocardial involvement: electrocardiographic and clinical profiling [0.03%]
急性心包炎ST段抬高与心肌受累：心电图及临床特征分析
Elisa Ceriani,Silvia Berra,Francesco Agozzino et al.
Elisa Ceriani et al.
Background: Pericardium is considered electrically inert, but diffuse ST-elevation is an electrocardiographic marker of acute pericarditis. We hypothesised that ST-elevation in acute pericarditis may reflect underlying my...
Multicenter Study
Open heart. 2026 Mar 18;13(1):e004019. DOI:10.1136/openhrt-2026-004019 2026
Amy Avakian,Muhammad Umair
Amy Avakian
Cinematic rendering (CR) is a three-dimensional visualisation technique that applies physically based lighting to standard volumetric CT and MRI datasets, producing images with enhanced depth and spatial realism. Although often regarded as ...
Björn Zethelius,Mats Talbäck,Rickard Ljung
Björn Zethelius
Objective: To analyse comorbidity measures in relation to cardiovascular disease risk, using data from Swedish healthcare registries. The aim was to evaluate the performance of different indices in predicting incidences o...
Observational Study
Open heart. 2026 Mar 16;13(1):e003999. DOI:10.1136/openhrt-2026-003999 2026
Association of Life's Simple 7 with metabolic-associated steatotic liver disease and non-invasive fibrosis markers [0.03%]
美国心脏协会生命简单7指标与代谢性关联脂肪型肝病及非侵入式纤维化标志物相关性研究
Hannah Hofer,Sarah Wernly,Georg Semmler et al.
Hannah Hofer et al.
Background: Metabolic-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease affecting approximately a third of the global population. Early identification is critical for timely intervention, yet...
Multicenter Study
Open heart. 2026 Mar 12;13(1):e003982. DOI:10.1136/openhrt-2026-003982 2026
Risk prediction modelling of 30-day all-cause mortality following percutaneous coronary intervention in an Australian population: leveraging machine learning [0.03%]
基于机器学习的经皮冠状动脉介入治疗后30天内全因死亡率预测模型：在澳大利亚人群中的研究
Mohammad Rocky Khan Chowdhury,Diem T Dinh,Angela Brennan et al.
Mohammad Rocky Khan Chowdhury et al.
Background: Preprocedural risk prediction of 30-day all-cause mortality after percutaneous coronary intervention (PCI) aids in clinical decision-making and benchmarking hospital performance. This study aimed to identify p...
Multicenter Study
Open heart. 2026 Mar 10;13(1):e003619. DOI:10.1136/openhrt-2025-003619 2026
Prognostic impact of corticosteroid maintenance dose and re-escalation in patients with cardiac sarcoidosis [0.03%]
心脏结节病患者皮质类固醇维持剂量和再增量的预后影响
Takuya Nishimura,Kohei Ishibashi,Koshiro Kanaoka et al.
Takuya Nishimura et al.
Background: Japanese guidelines recommend a corticosteroid maintenance dose of 5-10 mg/day for cardiac sarcoidosis (CS); however, the optimal dose remains unclear. This study aimed to evaluate the impact of maintenance do...
Multicenter Study
Open heart. 2026 Mar 6;13(1):e004048. DOI:10.1136/openhrt-2026-004048 2026
Retrospective analysis of the performance of the PROMISE minimal risk tool for patients presenting with recent onset stable chest pain [0.03%]
回顾性分析PROMISE最低风险评分工具在近期发作的稳定型胸痛患者中的表现
Conor Tuffs,Natasha Khullar,Terry Levy et al.
Conor Tuffs et al.
Introduction: The PRECISE study demonstrated that the Prospective multicentre imaging study for evaluation of chest pain (PROMISE) Minimal risk score (PMRS) can identify patients with recent onset stable chest pain who co...
Multicenter Study
Open heart. 2026 Mar 6;13(1):e003837. DOI:10.1136/openhrt-2025-003837 2026